Clinical Trial Update: Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bone marrow-derived mononuclear cells for myocardial regeneration has completed in patients with left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Asklepios proresearch | Conditions: Left Ventricular Dysfunction | Phase 3 | Status: COMPLETED